HIV trials in Argentina
9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- Where
- Buenos Aires, Ciudad Autonoma Buenos Aires, Córdoba, Rosario, San Miguel de Tucumán
- Age
- 12 years and over
- People
- 564 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07650916 · EU 2024-518511-19-00 - Phase 4Taking peopleA Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
- Where
- Buenos Aires
- Age
- 1 month and over
- People
- 350 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06337032 - Phase 2/3Taking peopleA Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Where
- Buenos Aires, Caba, CABA, Mar del Plata, Rosario, San Miguel de Tucumán
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07266831 · EU 2025-522519-40-00 - Phase 1Taking peopleA Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
- Where
- Buenos Aires
- Age
- 18 years to 60 years
- People
- 42 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07569029 - Phase 1/2Taking peopleVery Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- Where
- Buenos Aires
- Age
- Up to 48 hours
- People
- 1,120 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT02140255 - Phase 2Taking peopleA Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
- Where
- Buenos Aires, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Bueno, Mar del Plata, San Miguel de Tucumán
- Age
- 18 years and over
- People
- 186 worldwide
- Run by
- ViiV Healthcare
See details and how to joinNCT07202546 · EU 2025-521918-26-00 - Phase 3Not yet taking people in ArgentinaDuo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
- Where
- Buenos Aires
- Age
- 18 years to 29 years
- People
- 400 worldwide
- Run by
- HIV Prevention Trials Network
See details and how to joinNCT07658976 - Phase 4Taking peopleSwitch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
- Where
- Buenos Aires
- Age
- 18 years and over
- People
- 50
- Run by
- UBATEC
See details and how to joinNCT06967753 - No phaseEnrolling by invitationEuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
- Where
- Buenos Aires
- Age
- 16 years and over
- People
- 23,000 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02699736